Alexandria Real Estate Equities is thoroughly outperforming the Dow Jones U.S. Real Estate Index because of the high percentage of investment-grade biotech and pharma tenants it houses its buildings, says the company's CEO Joel Marcus. He says the fact that Alexandria's buildings are located in hot urban centers like New York, San Francisco and Cambridge is also a factor. Marcus says the cost of designing and maintaining buildings dedicated to science may be higher, but so are the rents.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

More from Video

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Abercrombie & Fitch CEO Reveals to TheStreet How She Is Turning Company Around

Abercrombie & Fitch CEO Reveals to TheStreet How She Is Turning Company Around

The Chart Professor: Worried About United Technologies Right Here

The Chart Professor: Worried About United Technologies Right Here

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Jim Cramer: I've Liked Six Flags Entertainment Stock as an Income Producer

Jim Cramer: I've Liked Six Flags Entertainment Stock as an Income Producer